‘Unexpected’ Vulnerability Creates Treatment Opportunity in Aggressive Type of Lung Cancer

A new study has identified a potentially critical vulnerability in lung cancers that have mutations in the KRAS gene, and showed that a drug already under study may be able to exploit it.

Cancer Currents: An NCI Cancer Research Blog